MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker.

Cobertura de los medios

• Nombre	MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker.
  Nombre/canal del medio de comunicación	Physicians Weekly
  País/Territorio	Estados Unidos
  Fecha	17/2/25
  URL	ct.moreover.com/?a=56041999860&p=1gw&v=1&x=2f2El9o9PAFtO2QgOqlD8A
  Personas	Yang Yang